Pulse Biosciences, Inc. (PLSE) Market Cap & Valuation Ratios
Pulse Biosciences, Inc. (PLSE) has a market cap of $3.8B and a price-to-sales ratio of 3191.2, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PLSEPulse Biosciences, Inc.Follow PLSE — free
—
Price chart with a free account
- Market cap
- 3.8B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 23 days
Peers
medical instruments & supplies · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| PLSE | 3.8 | — | — | — | -1.6% | — | — | — |
| BLCO | 6.2 | — | 2.1 | 15.0 | 2.2% | +9% | 6% | 2% |
| TFX | 5.8 | — | 3.7 | 43.0 | 2.9% | +31% | 2% | 0.6% |
| MMSI | 5.6 | 38.4 | 3.7 | 18.0 | 3.6% | +10% | 13% | 8% |
| MMED | 5.2 | — | 1.5 | — | -6.1% | +14% | -5% | -5% |
| MMEDV | 5.0 | — | — | — | — | +14% | -5% | -5% |
| ICUI | 4.2 | — | 2.4 | 18.7 | 3.7% | -9% | 3% | 1% |
| NVST | 3.8 | 40.7 | 1.4 | 10.5 | 6.5% | +12% | 10% | 3% |
| WRBY | 3.2 | — | 3.2 | 52.9 | 0.7% | +11% | 0.2% | 1% |
| ATRC | 3.0 | — | 5.1 | 85.7 | 1.8% | +14% | 2% | 3% |
| LMAT | 1.9 | 29.6 | 6.6 | 19.6 | 3.8% | +12% | 29% | 11% |
| Median of these 10 | 38.4 | 3.2 | 19.1 | 2.9% | +12% | 3% | 2% |
.
Growth vs. price
each dot a company · hover or tap for valuesPLSE and BLCO and TFX and MMED and MMEDV and ICUI and WRBY and ATRC have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Pulse Biosciences, Inc. — questions
- What is Pulse Biosciences, Inc.'s market cap?
- $3.8B.
- What is Pulse Biosciences, Inc.'s price-to-sales ratio?
- 3191.2.
Every figure on this page comes from Pulse Biosciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.